Cargando…

Taking Diabetes to Heart—Deregulation of Myocardial Lipid Metabolism in Diabetic Cardiomyopathy

Detalles Bibliográficos
Autores principales:	Bayeva, Marina, Sawicki, Konrad Teodor, Ardehali, Hossein
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2013
Materias:	Contemporary Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3886738/ https://www.ncbi.nlm.nih.gov/pubmed/24275630 http://dx.doi.org/10.1161/JAHA.113.000433

Ejemplares similares

Role of Heme in Cardiovascular Physiology and Disease
por: Sawicki, Konrad Teodor, et al.
Publicado: (2015)

Maternal Obesity and Diabetes Mellitus as Risk Factors for Congenital Heart Disease in the Offspring
por: Helle, Emmi, et al.
Publicado: (2020)

PCSK9 Inhibitors in Lipid Management of Patients With Diabetes Mellitus and High Cardiovascular Risk: A Review
por: Handelsman, Yehuda, et al.
Publicado: (2018)

Insights Into Aortic Sclerosis and Its Relationship With Coronary Artery Disease
por: Milin, Alexandra C., et al.
Publicado: (2014)

Circulating Biomarkers in Hypertrophic Cardiomyopathy
por: Matthia, Eldon L., et al.
Publicado: (2022)

Glucose Metabolism in Cardiac Hypertrophy and Heart Failure
por: Tran, Diem H., et al.
Publicado: (2019)

Evolving Diagnostic Criteria for Arrhythmogenic Cardiomyopathy
por: Corrado, Domenico, et al.
Publicado: (2021)

Sex‐Related Differences in Genetic Cardiomyopathies
por: Argirò, Alessia, et al.
Publicado: (2022)

Glucose Metabolism in the Kidney: Neurohormonal Activation and Heart Failure Development
por: Gronda, Edoardo, et al.
Publicado: (2020)

Association of Endocrine Conditions With Takotsubo Cardiomyopathy: A Comprehensive Review
por: Gupta, Sonali, et al.
Publicado: (2018)

Impact of Demographic Features, Lifestyle, and Comorbidities on the Clinical Expression of Hypertrophic Cardiomyopathy
por: Finocchiaro, Gherardo, et al.
Publicado: (2017)

Clinical Characteristics and Management of Methamphetamine‐Associated Cardiomyopathy: State‐of‐the‐Art Review
por: Reddy, Pavan K. V., et al.
Publicado: (2020)

Role of Targeted Therapy in Dilated Cardiomyopathy: The Challenging Road Toward a Personalized Approach
por: Verdonschot, Job A. J., et al.
Publicado: (2019)

Contemporary Insights Into the Genetics of Hypertrophic Cardiomyopathy: Toward a New Era in Clinical Testing?
por: Mazzarotto, Francesco, et al.
Publicado: (2020)

Lipid Levels and Use of Lipid-Lowering Drugs for Patients in Pharmacist-Managed Lipid Clinics Versus Usual Care in 2 VA Medical Centers
por: Mazzolini, Timothy A., et al.
Publicado: (2005)

Clinical Potential of Targeting Fibroblast Growth Factor‐23 and αKlotho in the Treatment of Uremic Cardiomyopathy
por: Law, Jonathan P., et al.
Publicado: (2020)

Platelet–Neutrophil Interaction and Thromboinflammation in Diabetes: Considerations for Novel Therapeutic Approaches
por: Gauer, Julia S., et al.
Publicado: (2022)

Longitudinal Assessment of a Diabetes Care Management System in an Integrated Health Network
por: Larsen, David L., et al.
Publicado: (2003)

Unraveling the Genotype‐Phenotype Relationship in Hypertrophic Cardiomyopathy: Obesity‐Related Cardiac Defects as a Major Disease Modifier
por: Nollet, Edgar E., et al.
Publicado: (2020)

Genomic, Proteomic, and Metabolic Comparisons of Small Animal Models of Heart Failure With Preserved Ejection Fraction: A Tale of Mice, Rats, and Cats
por: Smith, Alex N., et al.
Publicado: (2022)

Acute Myocardial Infarction: Etiologies and Mimickers in Young Patients
por: Krittanawong, Chayakrit, et al.
Publicado: (2023)

Tuberculosis and the Heart
por: López‐López, José Patricio, et al.
Publicado: (2021)

Blood–Brain Barrier Disruption, Vascular Impairment, and Ischemia/Reperfusion Damage in Diabetic Stroke
por: Venkat, Poornima, et al.
Publicado: (2017)

Cannabinoids, the Heart of the Matter
por: Alfulaij, Naghum, et al.
Publicado: (2018)

Maternal Heart Failure
por: Bright, Rachel A., et al.
Publicado: (2021)

Impact of Reperfusion on Temporal Immune Cell Dynamics After Myocardial Infarction
por: Zhang, Richard Ying Ke, et al.
Publicado: (2023)

Transatlantic Lipid Guideline Divergence: Same Data But Different Interpretations
por: Orringer, Carl E., et al.
Publicado: (2020)

Epigenetics in Congenital Heart Disease
por: Wang, Guanglei, et al.
Publicado: (2022)

Metabolic Suppression of HIF-1α Contributes to Susceptibility of Ischemic Injury in Diabetic Hearts
por: De Jesus, Adam, et al.
Publicado: (2018)

Lipid Management in Patients Presenting With Acute Coronary Syndromes: A Review
por: Claessen, Bimmer E., et al.
Publicado: (2020)

Scavenger Receptors in Myocardial Infarction and Ischemia/Reperfusion Injury: The Potential for Disease Evaluation and Therapy
por: Zhang, Jishou, et al.
Publicado: (2023)

Device‐Based Approaches Targeting Cardioprotection in Myocardial Infarction: The Expanding Armamentarium of Innovative Strategies
por: Romeo, Francisco José, et al.
Publicado: (2022)

Coronary Microvascular Injury in Reperfused Acute Myocardial Infarction: A View From an Integrative Perspective
por: Sezer, Murat, et al.
Publicado: (2018)

Arrhythmias After Heart Transplantation: Mechanisms and Management
por: Thajudeen, Anees, et al.
Publicado: (2012)

Pregnancy Complicated by Valvular Heart Disease: An Update
por: Nanna, Michael, et al.
Publicado: (2014)

Role of Monocytes in Heart Failure and Atrial Fibrillation
por: Shahid, Farhan, et al.
Publicado: (2018)

Current Landscape of Heart Failure Gene Therapy
por: Kieserman, Jake M., et al.
Publicado: (2019)

Role of Volume Redistribution in the Congestion of Heart Failure
por: Fudim, Marat, et al.
Publicado: (2017)

Degeneration of Bioprosthetic Heart Valves: Update 2020
por: Kostyunin, Alexander E., et al.
Publicado: (2020)

Stroke–Heart Syndrome: Recent Advances and Challenges
por: Scheitz, Jan F., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_u4n10l1cdvb1uqumm8lnc17hq6